161 related articles for article (PubMed ID: 1708983)
1. Novel therapy for the treatment of human carcinoid.
Evers BM; Hurlbut SC; Tyring SK; Townsend CM; Uchida T; Thompson JC
Ann Surg; 1991 May; 213(5):411-6. PubMed ID: 1708983
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.
Evers BM; Townsend CM; Upp JR; Allen E; Hurlbut SC; Kim SW; Rajaraman S; Singh P; Reubi JC; Thompson JC
Gastroenterology; 1991 Aug; 101(2):303-11. PubMed ID: 1712329
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.
Upp JR; Olson D; Poston GJ; Alexander RW; Townsend CM; Thompson JC
Am J Surg; 1988 Jan; 155(1):29-35. PubMed ID: 2893555
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs.
Imam H; Eriksson B; Lukinius A; Janson ET; Lindgren PG; Wilander E; Oberg K
Acta Oncol; 1997; 36(6):607-14. PubMed ID: 9408151
[TBL] [Abstract][Full Text] [Related]
6. A novel cytotoxic agent for human carcinoid tumors.
Litvak DA; Papaconstantinou HT; Ko TC; Townsend CM
Surgery; 1998 Dec; 124(6):1071-6. PubMed ID: 9854585
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of neuroendocrine gut and pancreatic tumors.
Oberg K; Eriksson B
Acta Oncol; 1989; 28(3):425-31. PubMed ID: 2472826
[TBL] [Abstract][Full Text] [Related]
8. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice.
Poston GJ; Townsend CM; Rajaraman S; Thompson JC; Singh P
Pancreas; 1990 Mar; 5(2):151-7. PubMed ID: 2156257
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo.
Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC
Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mouse bladder tumor proliferation by alpha difluoromethylornithine and interferon in vitro and in vivo.
Bahnson RR; Ratliff TL
J Urol; 1988 Jun; 139(6):1367-71. PubMed ID: 3131549
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
13. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
14. Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide.
Joensuu H; Kätkä K; Kujari H
Acta Endocrinol (Copenh); 1992 Feb; 126(2):184-5. PubMed ID: 1371898
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Endoh F; Ohta M; Togawa Y; Okui K
Jpn J Surg; 1986 Mar; 16(2):133-9. PubMed ID: 2941608
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of alpha-difluoromethylornithine and recombinant gamma-interferon.
Gohji K; Murao S; Maeda S; Sugiyama T; Kamidono S
Cancer Res; 1986 Dec; 46(12 Pt 1):6264-8. PubMed ID: 3096559
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
Miyake K; Tsuchida K; Sugino H; Imura S; Morine Y; Fujii M; Shimada M
Cancer Chemother Pharmacol; 2007 Jan; 59(1):113-26. PubMed ID: 16699793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
